Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia
Summary
The goal of this clinical trial is to learn if giving iron supplementation every other day is as effective as giving it daily in children with Iron Deficiency Anemia. The main questions it aims to answer are: 1. Will alternate day regimen improve hemoglobin and iron profile just as well as daily dose? 2. Which group will suffer less side effects from Iron Supplementation? Participants will be divided into two groups: Group A: will receive oral Iron supplementation daily for 2 months Group B: will receive oral Iron supplementation every other day for 2 months Participants will be monitored using weekly phone calls to insure compliance and report side effects. Both groups will be given Albendazole 400 mg once at the beginning of the study to be repeated in 1 week
Timeline
- Start
- 2024-01-01
- Primary completion
- 2025-01
- Completion
- 2025-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iron III Hydroxide Polymaltose Complex | Unknown | 3 mg/kg | Oral |
| Comparator | Iron III Hydroxide Polymaltose Complex | Unknown | 6 mg/kg | Oral |
| Background | Albendazole | Small molecule | 400 mg | — |